ClotCare: Blood Clots, Stroke, Heart Attack
Sunday, May 26, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

JCAHO DVT Risk Assessment Measures

Henry I. Bussey, Pharm.D.
June, 2006

Recently the Joint Commission for Accreditation of Healthcare Organizations (JCAHO) posted for open comment 19 proposed measures of DVT risk assessment, treatment, and outcomes. ClotCare encouraged its readers to provide their input. Although we have not seen information summarizing the public input on the 19 proposed measures, as of April, 2006, JCAHO has announced that 10 of the 19 proposed measures (listed below) will go forward with continued evaluation. Apparently, these will not take effect immediately because JCAHO plans to conduct an alpha test of these measures in the summer of 2006 and reassess the feasibility of implementing the measures and/or what modifications need to be made. The alpha test will be followed with a pilot trial in 2007. For more details of this process and related information to the development of these measures, visit the JCAHO website at

Risk Assessment/Prophylaxis

  • Documentation of Venous Thromboembolism Risk Assessment (RA)/Prophylaxis within 24 Hours of Hospital Admission
  • Documentation of Venous Thromboembolism Risk Assessment (RA)/Prophylaxis within 24 Hours of Transfer to ICU


  • Documentation of Inferior Vena Cava Filter Indication
  • Venous Thromboembolism Patients with Overlap of Parenteral and Warfarin Anticoagulation Therapy
  • Venous Thromboembolism Patients Receiving Unfractionated Heparin with Platelet Count Monitoring
  • Venous Thromboembolism Patients with Renal Insufficiency that Received Reduced/Discontinued Anticoagulation Therapy
  • Venous Thromboembolism Patients Receiving Unfractionated Heparin Management by Nomogram/Protocol
  • Venous Thromboembolism Discharge Instructions


  • Venous Thromboembolism Patients with International Normalized Ratio > 6 After Initiation of Warfarin Therapy
  • Incidence of Potentially Preventable Hospital-Acquired Venous Thromboembolism
Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to
Sunday, May 26, 2024